Plasmodium falciparum circumsporozoite vaccine immunogenicity and efficacy trial with natural challenge quantitation in an area of endemic human malaria of Kenya
- 30 June 1996
- Vol. 14 (8) , 817-827
- https://doi.org/10.1016/0264-410x(95)00221-l
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Safety, immunogenicity and limited efficacy study of a recombinant Plasmodium falciparum circumsporozoite vaccine in Thai soldiersVaccine, 1994
- Vaccination with SPf66, a chemically synthesised vaccine, against Plasmodium falciparum malaria in ColombiaThe Lancet, 1993
- On the function of repetitive domains in protein antigens of Plasmodium and other eukaryotic parasitesParasitology Today, 1991
- Quantitation of malaria sporozoites in the salivary glands of wild Afrotropical AnophelesMedical and Veterinary Entomology, 1991
- A malaria T-cell epitope recognized in association with most mouse and human MHC class II moleculesNature, 1988
- Immunity to Malaria and Naturally Acquired Antibodies to the Circumsporozoite Protein ofPlasmodium falciparumNew England Journal of Medicine, 1986
- In Vitro and in Vivo Results Suggesting That Anti-Sporozoite Antibodies Do Not Totally BlockPlasmodium falciparumSporozoite InfectivityNew England Journal of Medicine, 1986
- Research in Malaria VaccinesNew England Journal of Medicine, 1986
- Effect of Antibodies to Recombinant and Synthetic Peptides on P. falciparum Sporozoites in VitroScience, 1986
- Structure of the Gene Encoding the Immunodominant Surface Antigen on the Sporozoite of the Human Malaria Parasite Plasmodium falciparumScience, 1984